文献速递皮肤肿瘤

无色素性和低色素性黑色素瘤患者的表型和基因型分析

Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-03-15

基于布里斯班痣形态学研究2009至2016年纳入的1254名参与者,比较47例无色素性/低色素性黑色素瘤与389例色素性黑色素瘤患者的表型和7个候选基因多态性。无色素性/低色素性黑色素瘤患者年龄更大,红发、手部雀斑和晒伤倾向更常见,MC1R R/R基因型频率更高,并关联TYR rs1126809*A/A和PLA2G6 rs11570734*A/A。

要点

  • 无色素性/低色素性黑色素瘤患者较色素性黑色素瘤患者年龄更大(63.3±13.0 vs 54.6±15.3岁;P<0.001)。
  • 无色素性/低色素性黑色素瘤患者红发(34% vs 15%;P=0.01)、严重手部雀斑(13% vs 5%;P=0.01)和晒伤倾向(63% vs 44%;P=0.01)更常见。
  • MC1R R/R基因型在无色素性/低色素性黑色素瘤中更常见(31.1% vs 11%;P<0.001;OR 26.4 vs 5.9;对照1.0)。

核心结论

  • 了解无色素性/低色素性黑色素瘤的表型和基因型关联有助于预测这种难以诊断的黑色素瘤的风险和关联,可能最终辅助临床管理和患者皮肤自检。

研究设计与样本

  • 布里斯班痣形态学研究于2009至2016年招募1254名核心参与者,来自皮肤科门诊、私人皮肤科诊所、布里斯班纵向双生子研究和QSkin研究的志愿者。
  • 病例参与者有黑色素瘤个人史,对照参与者无黑色素瘤个人史。
  • 检测MC1R、TYR、HERC/OCA2、IRF4、MTAP、PLA2G6和MITF的单核苷酸多态性,比较无色素性/低色素性黑色素瘤与色素性黑色素瘤患者。

主要发现

  • 47名参与者至少有1个无色素性/低色素性黑色素瘤,389名参与者有色素性黑色素瘤。
  • 无色素性/低色素性黑色素瘤患者年龄显著大于色素性黑色素瘤参与者(63.3±13.0 vs 54.6±15.3岁;P<0.001)。
  • 无色素性/低色素性黑色素瘤患者较色素性黑色素瘤患者更常见红发(34% vs 15%;P=0.01)、严重手部雀斑(13% vs 5%;P=0.01)和晒伤倾向(63% vs 44%;P=0.01)。
  • MC1R R/R基因型在无色素性/低色素性黑色素瘤人群中更常见(31.1% vs 11%;P<0.001;OR 26.4 vs 5.9;对照1.0)。
  • 无色素性/低色素性黑色素瘤与TYR rs1126809*A/A [OR(95%CI)2.7(1.1-6.8) vs 1.2(0.8-1.9)]和PLA2G6 rs11570734*A/A [OR(95%CI)3.7(1.0-13.6) vs 1.3(0.9-2.0)]相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Amelanotic/hypomelanotic melanoma is associated with poorer outcomes due to a more advanced disease stage at diagnosis. OBJECTIVE: To determine phenotypic risks and genotypic associations with amelanotic/hypomelanotic melanoma to develop a clinical and genetic profile that could assist in identifying high-risk individuals. METHODS: The Brisbane Naevus Morphology Study conducted from 2009 to 2016 has recruited a core of 1254 participants. Participants were drawn from a combination of volunteers from dermatology outpatient clinics, private dermatology clinics, the Brisbane Longitudinal Twin Study and QSkin study. Case participants had a personal history of melanoma and control participants no personal history of melanoma. We specifically examined seven known candidate pigmentation and melanoma genes and pigmentary phenotypic characteristics in participants with amelanotic/hypomelanotic melanoma compared to pigmented melanomas. This assayed single nucleotide polymorphisms in MC1R, TYR, HERC/OCA2, IRF4, MTAP, PLA2G6 and MITF. RESULTS: Forty-seven participants had at least one amelanotic/hypomelanotic melanoma, and 389 had pigmented melanomas, with amelanotic/hypomelanotic melanoma patients significantly older than pigmented melanoma participants (63.3 ± 13.0 vs. 54.6 ± 15.3 years; P < 0.001). Amelanotic/hypomelanotic melanoma patients were more likely than pigmented melanoma patients to have red hair (34% vs. 15%; P = 0.01), severe hand freckling (13% vs. 5%; P = 0.01) and propensity to sunburn (63% vs. 44%; P = 0.01). MC1R R/R genotype was much more frequent in our amelanotic/hypomelanotic melanoma population (31.1% vs. 11%; P < 0.001; OR 26.4 vs. 5.9; control 1.0). Amelanotic/hypomelanotic melanoma was associated with TYR rs1126809*A/A [OR (CI 95%) 2.7 (1.1-6.8) vs. 1.2 (0.8-1.9)] and PLA2G6 rs11570734*A/A [OR (CI 95%) 3.7 (1.0-13.6) vs. 1.3 (0.9-2.0)]. The MTAP melanoma risk SNP genotype, associated with darker pigmentation, (rs4636294*A/A) was less common in amelanotic/hypomelanotic melanoma patients [OR (CI 95%) 0.8 (0.3-2.1) vs. 2.0 (1.3-3.1)]. CONCLUSIONS: Knowledge of phenotypic and genotypic associations of amelanotic/hypomelanotic melanoma can help predict risks and associations of this difficult to diagnose melanoma, which may ultimately assist clinical management and patient skin self-examination.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Rayner JE, McMeniman EK, Duffy DL, et al. Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients. J Eur Acad Dermatol Venereol. 2019. PMID: 30680790. doi:10.1111/jdv.15446

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。